Clinical trial planned

Clinical trial planned in collaboration with the University of Gothenberg

RSP Systems is initiating an explorative study in collaboration with Professor Per-Anders Jansson at Sahlgrenska Academy in Gothenburg. People with Type 1 diabetes, as well as people with insulin-requiring type 2 diabetes, are eligible to participate. In addition to investigating the improvement of technology accuracy, the study will contribute to the understanding of the dynamics between conservative blood glucose values and interstitial glucose values, the latter being the target of RSP technology.

The Laboratory and Professor Per-Anders Jansson are focused on metabolic disorders and diabetes. The laboratory supports and promotes research in translational medicines to improve health and to benefit society. Per-Anders Jansson is highly experienced within the field of diabetes and his expertise will greatly contribute to the explorative studies, supporting the development of the our non-invasive glucose monitoring technology.


Share on facebook
Share on twitter
Share on linkedin

More news

This highly competitive grant of E2.4 million (US$2.85 million) was awarded to RSP Systems, to assist in the continued development of our …

Digital health is a powerful force that will transform lives. RSP Systems’ non-invasive technology enables consumers to measure critical elements of blood …

RSP Systems has completed its Series B at a total amount of US$15.5 million to accelerate regulatory approval and manufacturing of the GlucoBeam, a …